1. Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study. Issue 4 (16th January 2020) Authors: Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppä, Sirpa; Follows, George; Lenz, Georg; Kim, Won Seog; Nagler, Arnon; Dimou, Maria; Demeter, Judit; Özcan, Muhit; Kosinova, Marina; Bouabdallah, Krimo; Morschhauser, Franck; Stevens, Don A.; Trevarthen, David; Munoz, Javier; Rodrigues, Lia... Journal: American journal of hematology Issue: Volume 95:Issue 4(2020:Apr.) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study. (6th September 2018) Authors: Van Cutsem, Eric; Martinelli, Erika; Cascinu, Stefano; Sobrero, Alberto; Banzi, Maria; Seitz, Jean‐François; Barone, Carlo; Ychou, Marc; Peeters, Marc; Brenner, Baruch; Hofheinz, Ralf Dieter; Maiello, Evaristo; André, Thierry; Spallanzani, Andrea; Garcia‐Carbonero, Rocio; Arriaga, Yull E.; Verma,... Journal: Oncologist Issue: Volume 24:Number 2(2019) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗